The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world cost effectiveness of first-line pembrolizumab for advanced melanoma: A population-based study by the Canadian Real-world Evidence Value for Cancer Drugs (CanREValue) Collaboration.
 
Timothy Hanna
No Relationships to Disclose
 
Suriya Aktar
No Relationships to Disclose
 
Vanessa Arciero
No Relationships to Disclose
 
Ning Liu
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose